1. Home
  2. GLPG vs FORD Comparison

GLPG vs FORD Comparison

Compare GLPG & FORD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • FORD
  • Stock Information
  • Founded
  • GLPG 1999
  • FORD 1961
  • Country
  • GLPG Belgium
  • FORD United States
  • Employees
  • GLPG N/A
  • FORD N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • FORD Plastic Products
  • Sector
  • GLPG Health Care
  • FORD Industrials
  • Exchange
  • GLPG Nasdaq
  • FORD Nasdaq
  • Market Cap
  • GLPG 2.1B
  • FORD 2.1B
  • IPO Year
  • GLPG 2005
  • FORD 1995
  • Fundamental
  • Price
  • GLPG $29.89
  • FORD $10.69
  • Analyst Decision
  • GLPG Hold
  • FORD
  • Analyst Count
  • GLPG 4
  • FORD 0
  • Target Price
  • GLPG $30.00
  • FORD N/A
  • AVG Volume (30 Days)
  • GLPG 209.6K
  • FORD 701.2K
  • Earning Date
  • GLPG 11-05-2025
  • FORD 08-14-2025
  • Dividend Yield
  • GLPG N/A
  • FORD N/A
  • EPS Growth
  • GLPG N/A
  • FORD N/A
  • EPS
  • GLPG N/A
  • FORD N/A
  • Revenue
  • GLPG $323,674,692.00
  • FORD $25,188,450.00
  • Revenue This Year
  • GLPG $1.77
  • FORD N/A
  • Revenue Next Year
  • GLPG $0.44
  • FORD N/A
  • P/E Ratio
  • GLPG N/A
  • FORD N/A
  • Revenue Growth
  • GLPG 5.43
  • FORD 6.11
  • 52 Week Low
  • GLPG $22.36
  • FORD $3.32
  • 52 Week High
  • GLPG $37.78
  • FORD $46.00
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 34.46
  • FORD 28.88
  • Support Level
  • GLPG $30.92
  • FORD $13.51
  • Resistance Level
  • GLPG $31.85
  • FORD $15.50
  • Average True Range (ATR)
  • GLPG 0.81
  • FORD 1.78
  • MACD
  • GLPG -0.27
  • FORD -0.89
  • Stochastic Oscillator
  • GLPG 1.70
  • FORD 2.92

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

Share on Social Networks: